NIMH Phytoestrogen, Depression Studies Begin Initial Enrollment
This article was originally published in The Tan Sheet
Executive Summary
Recruitment screening has begun for an NIH randomized, placebo-controlled clinical study on the effects of treatment with Novagen's Rimostil phytoestrogen supplement and raloxifene (Eli Lilly's Evista) on peri-menopausal depression